Banyan Biomarkers Overview

  • Founded
  • 2002
Founded
  • Status
  • Private
  • Employees
  • 22
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4.49M
Latest Deal Amount
  • Investors
  • 5

Banyan Biomarkers General Information

Description

Developer of biomarkers designed to improve outcomes for patients suffering from neurological injuries and diseases. The company's biomarkers aim to rule out the need for CT scans in patients with a suspected mild traumatic brain injury that is based on actual data and not subjective interpretation, enabling physicians to identify and triage patients that need additional medical assistance and benefits by reducing radiation exposure from unnecessary CT scans.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Biotechnology
Primary Office
  • 16470 West Bernardo Drive
  • Suite 100
  • San Diego, CA 92127
  • United States
+1 (760) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Banyan Biomarkers Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 16-Jun-2020 $4.49M 000.00 Completed Generating Revenue
6. Later Stage VC (Series A2) 06-Feb-2017 000.00 000.00 000.00 Completed Startup
5. Grant 23-Jul-2015 00000 000 Completed Startup
4. Later Stage VC (Series A1) 24-Feb-2014 000 000 000.00 Completed Startup
3. Grant 30-Jan-2014 00000 000 Completed Startup
2. Grant 03-Oct-2013 $13M $6M Completed Startup
1. Later Stage VC (Series A) 31-Jul-2013 $6M $6M 000.00 Completed Startup
To view Banyan Biomarkers’s complete valuation and funding history, request access »

Banyan Biomarkers Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 8,823,529 $0.000100 8% $0.68 $0.68 1x $0.68 16.58%
To view Banyan Biomarkers’s complete cap table history, request access »

Banyan Biomarkers Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of biomarkers designed to improve outcomes for patients suffering from neurological injuries and diseases. The
Laboratory Services (Healthcare)
San Diego, CA
22 As of 2021
000.00
0000000000 0 000.00

000000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000 000000000
Southborough, MA
00 As of 0000
000.00
00000000000 000.00

00000000

qua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commod
0000000000 000000000
Bethesda, MD
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Banyan Biomarkers Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NanoDx Venture Capital-Backed Southborough, MA 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Bethesda, MD 00 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Halifax, Canada 0 0000 000000000000 0000
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
To view Banyan Biomarkers’s complete competitors history, request access »

Banyan Biomarkers Executive Team (13)

Name Title Board Seat Contact Info
Ronald Hayes Ph.D Co-Founder, Chief Scientific Officer & Board Member
Henry Nordhoff Chief Executive Officer & Chairman
Steven Richieri Chief Operating Officer, President and Board Member
Amy Griffin Director, Corporate Operations
Nancy Denslow Ph.D Co-Founder & Board Member
You’re viewing 5 of 13 executive team members. Get the full list »

Banyan Biomarkers Board Members (9)

Name Representing Role Since
Andrew von Eschenbach MD Self Board Member 000 0000
Henry Nordhoff Banyan Biomarkers Chief Executive Officer & Chairman 000 0000
Herbert Boyer Ph.D Self Board Member 000 0000
Nancy Denslow Ph.D Banyan Biomarkers Co-Founder & Board Member 000 0000
Ronald Hayes Ph.D Banyan Biomarkers Co-Founder, Chief Scientific Officer & Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Banyan Biomarkers Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Banyan Biomarkers Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anzu Partners Venture Capital Minority 000 0000 000000 0
BioMérieux Corporation Minority 000 0000 000000 0
General Electric Corporation 000 0000 000000 0
NFL Pension Plan Limited Partner 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
To view Banyan Biomarkers’s complete investors history, request access »